AU7786387A - Composition of matter and method of immunizing against viral causative agents of aids and arc - Google Patents
Composition of matter and method of immunizing against viral causative agents of aids and arcInfo
- Publication number
- AU7786387A AU7786387A AU77863/87A AU7786387A AU7786387A AU 7786387 A AU7786387 A AU 7786387A AU 77863/87 A AU77863/87 A AU 77863/87A AU 7786387 A AU7786387 A AU 7786387A AU 7786387 A AU7786387 A AU 7786387A
- Authority
- AU
- Australia
- Prior art keywords
- aids
- arc
- matter
- composition
- against viral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88874286A | 1986-07-21 | 1986-07-21 | |
US888742 | 1992-05-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7786387A true AU7786387A (en) | 1988-02-10 |
Family
ID=25393799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU77863/87A Abandoned AU7786387A (en) | 1986-07-21 | 1987-07-20 | Composition of matter and method of immunizing against viral causative agents of aids and arc |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0276279A4 (en) |
JP (1) | JPH01500432A (en) |
AU (1) | AU7786387A (en) |
DK (1) | DK149188A (en) |
WO (1) | WO1988000471A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU635217B2 (en) * | 1988-08-27 | 1993-03-18 | Akzo N.V. | Synthetic peptides immunochemically reactive with hiv-antibodies |
AU640615B2 (en) * | 1988-08-26 | 1993-09-02 | Akzo N.V. | Synthetic polypeptides immunochemically reactive with hiv-antibodies |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4772547A (en) * | 1986-02-03 | 1988-09-20 | Hoffmann-La Roche Inc. | HTLV-III envelope peptides |
US5126399A (en) * | 1986-04-30 | 1992-06-30 | Board Of Regents, The University Of Texas System | Methods and compositions for the preparation and use of site-directed immunologic reagents |
EP0255190A3 (en) * | 1986-08-01 | 1990-08-29 | Repligen Corporation | Recombinant polypeptides and their uses, inclusing assay for aids virus |
US5166050A (en) * | 1986-08-20 | 1992-11-24 | Bristol-Myers Squibb Company | Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections |
US5763160A (en) * | 1988-02-12 | 1998-06-09 | United Biomedical, Inc. | Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines |
CA1341285C (en) * | 1988-02-12 | 2001-08-14 | Chang Yi Wang | Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines |
US5562905A (en) * | 1988-04-26 | 1996-10-08 | E. I. Du Pont De Nemours And Company | Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals |
KR900701836A (en) * | 1988-10-03 | 1990-12-04 | 라메쉬 엘. 라탄 | Peptides useful for diagnosing, preventing or treating new HIV proteins and AIDS |
IL94558A0 (en) * | 1989-06-06 | 1991-03-10 | Merck & Co Inc | Conjugate immunogen for aids and vaccine and pharmaceutical compositions containing it |
US6248574B1 (en) * | 1989-12-13 | 2001-06-19 | Avigdor Shaffermann | Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides |
EP0448095A1 (en) * | 1990-03-21 | 1991-09-25 | Wolf, Hans Joachim, Prof. Dr. | Subregion of the retroviral ENV protein, DNA sequences encoding it and compositions for the diagnosis, prevention or therapy of retrovirus infections |
CA2047073A1 (en) * | 1990-07-19 | 1992-01-20 | William J. Leanza | Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties |
US5346989A (en) * | 1990-08-22 | 1994-09-13 | Syntello Vaccine Development Kb | Peptides for use in induction of T cell activation against HIV-1 |
FR2677654B1 (en) * | 1991-06-17 | 1995-11-17 | Pasteur Merieux Serums Vacc | COMPOUNDS WITH AN IMMUNOGENIC ANTI-CYTOKIN EFFECT, AN ANTIYTOSTATIC IMMUNOGENIC EFFECT OR AN ANTI-HIV INFECTION VACCINE EFFECT. |
US5274122A (en) * | 1992-10-15 | 1993-12-28 | Merck & Co., Inc. | Acidic derivatives of homocysteine thiolactone |
DE4417742A1 (en) | 1994-05-20 | 1995-11-23 | Bayer Ag | Non-systemic control of parasites |
US7935805B1 (en) | 1998-12-31 | 2011-05-03 | Novartis Vaccines & Diagnostics, Inc | Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof |
WO2000039304A2 (en) | 1998-12-31 | 2000-07-06 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
DE69938062T2 (en) | 1998-12-31 | 2009-01-15 | Novartis Vaccines and Diagnostics, Inc., Emeryville | MODIFIED HIV ENV POLYPEPTIDE |
EP1141313A2 (en) | 1998-12-31 | 2001-10-10 | Chiron Corporation | Improved expression of hiv polypeptides and production of virus-like particles |
US6659681B1 (en) | 1999-02-10 | 2003-12-09 | Traf Fix Devices, Inc. | Laterally stable vertical panel system |
JP5033303B2 (en) | 2001-07-05 | 2012-09-26 | ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド | Polynucleotides encoding polypeptides with antigenic type C HIV, polypeptides and uses thereof |
US20030170614A1 (en) | 2001-08-31 | 2003-09-11 | Megede Jan Zur | Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof |
EP1427806A4 (en) | 2001-08-31 | 2006-04-26 | Chiron Corp | Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
CN106257728B (en) | 2016-01-28 | 2018-01-12 | 中国科学院过程工程研究所 | A kind of system and method for producing the high-purity V electrolyte of 3.5 valencys |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL61904A (en) * | 1981-01-13 | 1985-07-31 | Yeda Res & Dev | Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same |
US4629783A (en) * | 1985-04-29 | 1986-12-16 | Genetic Systems Corporation | Synthetic antigen for the detection of AIDS-related disease |
JP2702911B2 (en) * | 1985-09-11 | 1998-01-26 | ユナイテツド・バイオメデイカル・インコ−ポレ−テツド | Synthetic peptide, and method for detecting AIDS and pre-AIDS using the same |
-
1987
- 1987-07-20 AU AU77863/87A patent/AU7786387A/en not_active Abandoned
- 1987-07-20 WO PCT/US1987/001733 patent/WO1988000471A1/en not_active Application Discontinuation
- 1987-07-20 EP EP19870905089 patent/EP0276279A4/en not_active Withdrawn
- 1987-07-20 JP JP62504599A patent/JPH01500432A/en active Pending
-
1988
- 1988-03-18 DK DK149188A patent/DK149188A/en not_active Application Discontinuation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU640615B2 (en) * | 1988-08-26 | 1993-09-02 | Akzo N.V. | Synthetic polypeptides immunochemically reactive with hiv-antibodies |
AU635217B2 (en) * | 1988-08-27 | 1993-03-18 | Akzo N.V. | Synthetic peptides immunochemically reactive with hiv-antibodies |
Also Published As
Publication number | Publication date |
---|---|
DK149188D0 (en) | 1988-03-18 |
EP0276279A1 (en) | 1988-08-03 |
EP0276279A4 (en) | 1990-01-08 |
DK149188A (en) | 1988-05-06 |
JPH01500432A (en) | 1989-02-16 |
WO1988000471A1 (en) | 1988-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7786387A (en) | Composition of matter and method of immunizing against viral causative agents of aids and arc | |
AU4205789A (en) | Method and composition for the treatment and prevention of viral infections | |
AU564694B2 (en) | Blends of polyetherimide and organosiloxane-polycarbonate block copolymers | |
AU559545B2 (en) | Composition and method for treatment of glaucoma | |
AU7211787A (en) | Intraocular dosage compositions and method of use | |
AU1550983A (en) | Blends of polyetherimide and organosiloxane-polycarbonate block copolymers | |
AU1952288A (en) | Method of selectively inhibiting hiv | |
AU8367991A (en) | Method of purifying bisphenol-a | |
AU6110990A (en) | Use of viruses against undesirable micro-organisms | |
AU5064985A (en) | Methods and compositions for treating viral infection | |
AU6979487A (en) | Treatment of gases | |
AU2855589A (en) | Method and composition for accelerating the hardening of cements and removing efflorescent effects | |
AU3413389A (en) | Method of treating retrovirus infection | |
AU5568290A (en) | Method of suppressing hiv infection | |
AU6796287A (en) | Method and composition for prophylaxis and treatment of viral infections | |
AU7515287A (en) | Methods and compositions for treating viral infections | |
AU582303B2 (en) | Method of curve approximation | |
AU6660090A (en) | Treatment of depression | |
ZA87470B (en) | Method and composition for prophylaxis and treatment of viral infections | |
AU7120987A (en) | Composition for and method of treating aids and certain related diseases | |
AU5314886A (en) | Method of detaching micro-flora and compositions therefor | |
AU628643B2 (en) | Strain of myxococcus | |
AU4829190A (en) | Methods and compositions for the prophylaxis and treatment of hepatitis b virus infections | |
OA09507A (en) | Compositions and methods for treating or preventing AIDS ARC and HIV infection | |
AU7360387A (en) | Bacteriocins used for anti-viral treatment (particularly aids) |